Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
The global immunotherapy drugs market size reached US$ 195.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 327.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2023-2028.
Immunotherapy drugs are specialized medications used for treating lymphoma, melanoma, sarcoma, and lung, bladder, kidney, and breast cancer. They target specific cells of the immune system and boost energy levels. They stimulate the natural defenses of the body and help fight against allergies and infections caused by bacteria and viruses. They also aid in preventing the growth of cancer cells by triggering an immunological response that aids in generating antibodies. Moreover, as they are effective in minimizing the complications of tumors and other chronic disorders, the demand for immunotherapy drugs is rising across the globe.
Immunotherapy Drugs Market Trends:
The growing global geriatric population and the rising prevalence of cancer, tumor, and target diseases worldwide represent one of the key factors positively influencing the market. In addition, hectic schedules and the increasing occurrence of various genetic and lifestyle diseases are catalyzing the demand for immunotherapy drugs across the globe. Apart from this, the escalating demand for monoclonal antibodies and biosimilar drugs is offering lucrative growth opportunities to manufacturers. This, in confluence with the rising awareness among individuals and healthcare professionals about the benefits of early diagnosis and treatment of cancer, is increasing the overall sales of immunotherapy drugs. Furthermore, the increasing focus of key market players on strategic collaborations and new product developments to expand their product portfolio and gain a competitive edge is propelling the market growth. Additionally, the expansion of hospitals, pharmacies, and research laboratories across the globe is offering a favorable market outlook. Moreover, increasing investments by leading pharmaceutical and biotechnology companies in research and development (R&D) activities to enhance the formulation of immunotherapy drugs are expected to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global immunotherapy drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, therapy area and end user.
Breakup by Type:
Monoclonal Antibodies
Vaccines
Interferons Alpha and Beta
Interleukins
Breakup by Therapy Area:
Cancer
Autoimmune and Inflammatory Diseases
Infectious Diseases
Others
Breakup by End User:
Hospitals
Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GSK plc, Merck & Co. Inc., Pfizer Inc. and Sanofi S.A. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global immunotherapy drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global immunotherapy drugs market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the therapy area?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global immunotherapy drugs market and who are the key players?
What is the degree of competition in the industry?
Immunotherapy drugs are specialized medications used for treating lymphoma, melanoma, sarcoma, and lung, bladder, kidney, and breast cancer. They target specific cells of the immune system and boost energy levels. They stimulate the natural defenses of the body and help fight against allergies and infections caused by bacteria and viruses. They also aid in preventing the growth of cancer cells by triggering an immunological response that aids in generating antibodies. Moreover, as they are effective in minimizing the complications of tumors and other chronic disorders, the demand for immunotherapy drugs is rising across the globe.
Immunotherapy Drugs Market Trends:
The growing global geriatric population and the rising prevalence of cancer, tumor, and target diseases worldwide represent one of the key factors positively influencing the market. In addition, hectic schedules and the increasing occurrence of various genetic and lifestyle diseases are catalyzing the demand for immunotherapy drugs across the globe. Apart from this, the escalating demand for monoclonal antibodies and biosimilar drugs is offering lucrative growth opportunities to manufacturers. This, in confluence with the rising awareness among individuals and healthcare professionals about the benefits of early diagnosis and treatment of cancer, is increasing the overall sales of immunotherapy drugs. Furthermore, the increasing focus of key market players on strategic collaborations and new product developments to expand their product portfolio and gain a competitive edge is propelling the market growth. Additionally, the expansion of hospitals, pharmacies, and research laboratories across the globe is offering a favorable market outlook. Moreover, increasing investments by leading pharmaceutical and biotechnology companies in research and development (R&D) activities to enhance the formulation of immunotherapy drugs are expected to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global immunotherapy drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, therapy area and end user.
Breakup by Type:
Monoclonal Antibodies
Vaccines
Interferons Alpha and Beta
Interleukins
Breakup by Therapy Area:
Cancer
Autoimmune and Inflammatory Diseases
Infectious Diseases
Others
Breakup by End User:
Hospitals
Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GSK plc, Merck & Co. Inc., Pfizer Inc. and Sanofi S.A. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global immunotherapy drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global immunotherapy drugs market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the therapy area?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global immunotherapy drugs market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL IMMUNOTHERAPY DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG TYPE
6.1 Monoclonal Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Vaccines
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Interferons Alpha and Beta
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Interleukins
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY THERAPY AREA
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Autoimmune and Inflammatory Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Infectious Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AstraZeneca plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Boehringer Ingelheim International GmbH
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 F. Hoffmann-La Roche AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 GSK plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Merck & Co. Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL IMMUNOTHERAPY DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG TYPE
6.1 Monoclonal Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Vaccines
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Interferons Alpha and Beta
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Interleukins
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY THERAPY AREA
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Autoimmune and Inflammatory Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Infectious Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AstraZeneca plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Boehringer Ingelheim International GmbH
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 F. Hoffmann-La Roche AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 GSK plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Merck & Co. Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report
LIST OF TABLES
Table 1: Global: Immunotherapy Drugs Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Immunotherapy Drugs Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Immunotherapy Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2023-2028
Table 4: Global: Immunotherapy Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Immunotherapy Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Immunotherapy Drugs Market: Competitive Structure
Table 7: Global: Immunotherapy Drugs Market: Key Players
Table 1: Global: Immunotherapy Drugs Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Immunotherapy Drugs Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Immunotherapy Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2023-2028
Table 4: Global: Immunotherapy Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Immunotherapy Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Immunotherapy Drugs Market: Competitive Structure
Table 7: Global: Immunotherapy Drugs Market: Key Players
LIST OF FIGURES
Figure 1: Global: Immunotherapy Drugs Market: Major Drivers and Challenges
Figure 2: Global: Immunotherapy Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Immunotherapy Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Immunotherapy Drugs Market: Breakup by Type (in %), 2022
Figure 5: Global: Immunotherapy Drugs Market: Breakup by Therapy Area (in %), 2022
Figure 6: Global: Immunotherapy Drugs Market: Breakup by End User (in %), 2022
Figure 7: Global: Immunotherapy Drugs Market: Breakup by Region (in %), 2022
Figure 8: Global: Immunotherapy Drugs (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Immunotherapy Drugs (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Immunotherapy Drugs (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Immunotherapy Drugs (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Immunotherapy Drugs (Interferons Alpha and Beta) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Immunotherapy Drugs (Interferons Alpha and Beta) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Immunotherapy Drugs (Interleukins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Immunotherapy Drugs (Interleukins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Immunotherapy Drugs (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Immunotherapy Drugs (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Immunotherapy Drugs (Autoimmune and Inflammatory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Immunotherapy Drugs (Autoimmune and Inflammatory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Immunotherapy Drugs (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Immunotherapy Drugs (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Immunotherapy Drugs (Other Therapy Areas) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Immunotherapy Drugs (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Immunotherapy Drugs (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Immunotherapy Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Immunotherapy Drugs (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Immunotherapy Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Immunotherapy Drugs (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Immunotherapy Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia-Pacific: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia-Pacific: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Immunotherapy Drugs Market: Breakup by Country (in %), 2022
Figure 78: Middle East and Africa: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Global: Immunotherapy Drugs Industry: SWOT Analysis
Figure 80: Global: Immunotherapy Drugs Industry: Value Chain Analysis
Figure 81: Global: Immunotherapy Drugs Industry: Porter's Five Forces Analysis
Figure 1: Global: Immunotherapy Drugs Market: Major Drivers and Challenges
Figure 2: Global: Immunotherapy Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Immunotherapy Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Immunotherapy Drugs Market: Breakup by Type (in %), 2022
Figure 5: Global: Immunotherapy Drugs Market: Breakup by Therapy Area (in %), 2022
Figure 6: Global: Immunotherapy Drugs Market: Breakup by End User (in %), 2022
Figure 7: Global: Immunotherapy Drugs Market: Breakup by Region (in %), 2022
Figure 8: Global: Immunotherapy Drugs (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Immunotherapy Drugs (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Immunotherapy Drugs (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Immunotherapy Drugs (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Immunotherapy Drugs (Interferons Alpha and Beta) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Immunotherapy Drugs (Interferons Alpha and Beta) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Immunotherapy Drugs (Interleukins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Immunotherapy Drugs (Interleukins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Immunotherapy Drugs (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Immunotherapy Drugs (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Immunotherapy Drugs (Autoimmune and Inflammatory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Immunotherapy Drugs (Autoimmune and Inflammatory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Immunotherapy Drugs (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Immunotherapy Drugs (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Immunotherapy Drugs (Other Therapy Areas) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Immunotherapy Drugs (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Immunotherapy Drugs (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Immunotherapy Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Immunotherapy Drugs (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Immunotherapy Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Immunotherapy Drugs (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Immunotherapy Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia-Pacific: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia-Pacific: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Immunotherapy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Immunotherapy Drugs Market: Breakup by Country (in %), 2022
Figure 78: Middle East and Africa: Immunotherapy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Global: Immunotherapy Drugs Industry: SWOT Analysis
Figure 80: Global: Immunotherapy Drugs Industry: Value Chain Analysis
Figure 81: Global: Immunotherapy Drugs Industry: Porter's Five Forces Analysis
